Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J Argibay is active.

Publication


Featured researches published by J Argibay.


European Journal of Pharmacology | 1998

An agonist-like monoclonal antibody against the human β2-adrenoceptor

Diane Lebesgue; Gerd Wallukat; Alfredo Mijares; Claude Granier; J Argibay; Johan Hoebeke

Monoclonal antibodies were produced against a peptide corresponding to the second extracellular loop of the human beta2-adrenoceptor. One of these monoclonals, inducing an agonist-like effect in neonatal rat cardiomyocytes, was used to define the structural and physiological basis of this activity. The epitope recognized by the antibody corresponds to the sequence Trp-Tyr-Arg-Ala-Thr-His-Gln-Glu as determined by peptide scanning. Analysis by alanine modification of the peptide epitope showed the importance of the Trp, and Glu residues in antibody recognition The apparent affinity of the antibody assessed either by surface plasmon resonance or by functional titration on its agonist-like activity showed a similar value (10(8) M(-1)). The antibody recognized the receptor in its native form as shown by immunofluorescence experiments on A431 cells but not in its denatured form as shown by its absence of staining in immunoblots. The positive chronotropic effect in vitro was specifically blocked by both the antigenic peptide and the specific beta2-antagonist (+/-)-1-[2,3-(Dihydro-7-methyl1H-inden-4-yl)oxy]-3-[(1-methy lethyl)amino]-2-butanol hydrochloride (ICI1118,551). This activity was mediated through activation of Ca2+ L-type channels as assessed in guinea pig cardiomyocytes. These results suggest that the epitope is located in an extracellular alpha-helix, whose recognition by the antibody could stabilize the receptor in its active conformation.


Cardiovascular Research | 1995

Effect of sulfhydryl oxidation on ionic and gating currents associated with L-type calcium channels in isolated guinea-pig ventricular myocytes

Alain Lacampagne; Anne Duittoz; Pura Bolaños; Nicolas Peineau; J Argibay

OBJECTIVEnL-type calcium currents (ICa) and gating currents modification by extracellular application of the selective free sulfhydryl oxidant p-hydroxy-mercuric-phenylsulphonic acid (PHMPS) were studied.nnnMETHODSnBoth currents were obtained with the whole cell patch clamp technique in guinea-pig ventricular cardiocytes.nnnRESULTSnThe main finding was a reduction of ICa clearly differentiable from a run down process. This effect was protected, stopped and in some cases partially reversed by dithiothreitol, a protective reagent for -SH groups. We also found a decrease of the gating currents associated with L-type calcium channels. The calcium modulation and cAMP phosphorylation systems of ICa are unaffected by PHMPS. With barium as charge carrier the current-voltage curves of barium currents were shifted by 10 mV to the positive direction by PHMPS. The same effect was obtained with calcium currents using BAPTA as a fast calcium buffer.nnnCONCLUSIONnThe results indicate that oxidation of -SH groups carried by the channel protein induces dysfunction of the calcium entry to cardiac cells by altering the gating process. A participation of thiol functions on the gating of the calcium channel is proposed.


Journal of Molecular and Cellular Cardiology | 2010

5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes.

Mickaël Derangeon; V Bozon; Norah Defamie; Nicolas Peineau; Nicolas Bourmeyster; Denis Sarrouilhe; J Argibay; Jean-Claude Hervé

5-hydroxytryptamine-4 (5-HT(4)) receptors have been proposed to contribute to the generation of atrial fibrillation in human atrial myocytes, but it is unclear if these receptors are present in the hearts of small laboratory animals (e.g. rat). In this study, we examined presence and functionality of 5-HT(4) receptors in auricular myocytes of newborn rats and their possible involvement in regulation of gap junctional intercellular communication (GJIC, responsible for the cell-to-cell propagation of the cardiac excitation). Western-blotting assays showed that 5-HT(4) receptors were present and real-time RT-PCR analysis revealed that 5-HT(4b) was the predominant isoform. Serotonin (1 microM) significantly reduced cAMP concentration unless a selective 5-HT(4) inhibitor (GR113808 or ML10375, both 1 microM) was present. Serotonin also reduced the amplitude of L-type calcium currents and influenced the strength of GJIC without modifying the phosphorylation profiles of the different channel-forming proteins or connexins (Cxs), namely Cx40, Cx43 and Cx45. GJIC was markedly increased when serotonin exposure occurred in presence of a 5-HT(4) inhibitor but strongly reduced when 5-HT(2A) and 5-HT(2B) receptors were inhibited, showing that activation of these receptors antagonistically regulated GJIC. The serotoninergic response was completely abolished when 5-HT(4), 5-HT(2A) and 5-HT(2B) were simultaneously inhibited. A 24 h serotonin exposure strongly reduced Cx40 expression whereas Cx45 was less affected and Cx43 still less. In conclusion, this study revealed that 5-HT(4) (mainly 5-HT(4b)), 5-HT(2A) and 5-HT(2B) receptors coexisted in auricular myocytes of newborn rat, that 5-HT(4) activation reduced cAMP concentration, I(Ca)(L) and intercellular coupling whereas 5-HT(2A) or 5-HT(2B) activation conversely enhanced GJIC.


Receptors & Channels | 2004

High Efficiency Activation of L-Type Ca2+ Current by 5-HT in Human Atrial Myocytes

Emmanuella Di Scala; Ian Findlay; S Rose; Michel Aupart; J Argibay; Pierre Cosnay; V Bozon

In human atrial myocytes, serotonin rather than sympathetic, stimulation is more frequently associated with atrial fibrillation. So does the arrhythmogenic effect of serotonin result from the mechanism of action of the receptor or the context of its action upon cardiac myocytes? The capacity of agonists to produce cAMP followed the sequence 5-HT < Iso < Forskolin to increase ICaL with 5-HT = Iso = Forskolin. The simultaneous application of threshold concentrations of 5-HT and Iso maximally increased ICaL. We will show that the effect of 5-HT upon human atrial myocytes is an imbalance between low production of cAMP and maximal activation of ICaL.


Receptors & Channels | 2004

Polyclonal Antibody Effects on the Human Cardiac 5-HT4(e) Receptors Depend Upon the Expression System

Emmanuella Di Scala; S Rose; Olivier Herault; J Argibay; Pierre Cosnay; V Bozon

The initial objective of this work was to examine the effects of an antibody (Anti-G21V) directed against the second extracellular loop of human heart 5-HT4 receptors expressed in Chinese hamster ovary (CHO) cells. The antibody anti-G21V had no effect upon either basal cAMP-or 5-HT-evoked increases in cAMP in CHO cells, whereas it had shown an agonist-like effect in COS-7 cells. Analysis of agonist fractions of h5-HT4(e) receptors in CHO and COS-7 cells revealed that equilibrium constant could underlie the different responses of the receptor toward the anti-G21V antibody. Therefore, different expression systems could give rise to functional differences in 5-HT4 receptor behavior.


Journal of Molecular and Cellular Cardiology | 2001

Inhibitory Activity of Antibodies Against the Human Atrial 5-HT4Receptor ☆

Laurent Sallé; Pierre Eftekhari; Michel Aupart; Pierre Cosnay; Johan Hoebeke; J Argibay


Biochemical Pharmacology | 2007

Conformational state of human cardiac 5-HT4(g) receptors influences the functional effects of polyclonal anti-5-HT4 receptor antibodies

Emmanuella Di Scala; S Rose; Olivier Herault; J Argibay; Pierre Cosnay; V Bozon


Journal of Molecular and Cellular Cardiology | 2006

Cardiac 5_HT4 receptor in children: functional and pharmacological characteristics

A. Fitou; E. Bergöend; D. Gennetay; M. Pingaud; A. Tahir; P. Neville; M. Aupart; M. Marchand; J Argibay; Pierre Cosnay; V Bozon


Congrès Groupe de Reflexion sur la Recherche Cardiovasculaire | 2004

Presence of auto-antibodies directed against cardiac 5-HT4 receptor in sera of patients with atrial fibrillation

Emmanuella Di Scala; S Rose; D Gennetay; M Pingaud; Pierre Cosnay; J Argibay; V Bozon


“Seven annual meeting on health science and technology” Ecole doctorale santé, sciences et technologie de Tours | 2003

Etude du récepteur h5-HT4(e)

Emmanuella Di Scala; S Rose; D Gennetay; M Pingaud; J Argibay; Pierre Cosnay; V Bozon

Collaboration


Dive into the J Argibay's collaboration.

Top Co-Authors

Avatar

Pierre Cosnay

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

V Bozon

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

Emmanuella Di Scala

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

S Rose

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

Nicolas Peineau

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Didier Garnier

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

A. Fitou

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

Alfredo Mijares

François Rabelais University

View shared research outputs
Top Co-Authors

Avatar

D. Gennetay

François Rabelais University

View shared research outputs
Researchain Logo
Decentralizing Knowledge